The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design

Annette von Delft; Isla S Humphreys; Anthony Brown; Katja Pfafferott; Michaela Lucas; Paul Klenerman; Georg M Lauer; Andrea L Cox; Silvana Gaudieri; Eleanor Barnes

doi:10.1136/gutjnl-2014-308724

Article info

PDF

PDF +
Supplementary
Material

XML

Hepatology

Original article

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design

Authors

Annette von Delft NDM, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles
Isla S Humphreys NDM, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles
Anthony Brown NDM, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles
Katja Pfafferott NDM, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles
Michaela Lucas Institute of Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia School of Medicine and Pharmacology, Harry Perkins Institute, University of Western Australia, Western Australia, Australia School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia PubMed articles Google scholar articles
Paul Klenerman NDM, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles
Georg M Lauer Ragon Institute of MGH, Boston, Massachusetts, USA PubMed articles Google scholar articles
Andrea L Cox John Hopkins University, Baltimore, Maryland, USA PubMed articles Google scholar articles
Silvana Gaudieri Institute of Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia School of Anatomy, Physiology and Human Biology, University of Western Australia, Perth, Western Australia, Australia PubMed articles Google scholar articles
Eleanor Barnes NDM, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles

Correspondence to Prof Eleanor Barnes, The Peter Medawar Building for Pathogen Research, South Parks Road, Oxford OX1 3SY, UK; ellie.barnes{at}ndm.ox.ac.uk

View Full Text

Citation

von Delft A, Humphreys IS, Brown A, et al

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design

Gut 2016;65:112-123.

Publication history

Received October 27, 2014
Revised April 18, 2015
Accepted April 20, 2015
First published June 19, 2015.

Online issue publication

April 18, 2016

Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1 - Online supplement

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Supplementary Data

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password